Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Ethylenediamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 4/20 | 0.40 |
| ▸ | CA6 | P23280 | 4/20 | 0.40 |
| ▸ | CA7 | P43166 | 4/20 | 0.40 |
| ▸ | CA9 | Q16790 | 4/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.40 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.40 |
| ▸ | CA2 | P00918 | 3/20 | 0.40 |
| ▸ | CA3 | P07451 | 3/20 | 0.40 |
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CA5A | P35218 | 3/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylenediamine SCHEMBL11504925 | 1.00 | — | — | |
| Ethylenediamine SCHEMBL10902552 | 1.00 | — | — | |
| Ethylenediamine SCHEMBL1007637 | 1.00 | — | — | |
| Ethylenediamine SCHEMBL29613193 | 0.93 | — | — | |
| Ethylenediamine SCHEMBL22027728 | 0.93 | — | — | |
| Ethylenediamine SCHEMBL7085968 | 0.91 | NFKB1 (0.50) | NFKB1TSHRCA12CA6CA7 | |
| Ethylenediamine SCHEMBL37647 | 0.91 | — | — | |
| Ethylenediamine SCHEMBL3083 | 0.91 | — | — | |
| Ethylenediamine SCHEMBL28924405 | 0.91 | NFKB1 (0.50) | NFKB1TSHRCA12CA6CA7 | |
| Ethylenediamine SCHEMBL30253568 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122054810-A | Perovskite passivation layer, preparation material thereof and solar cell | 北京曜能科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-121398350-A | Solar cell, preparation method thereof and photovoltaic module | 通威太阳能（成都）有限公司 | 2026-01-23 | — | — | CN | disclosed |
| EP-4679984-A1 | PHOTOELECTRIC CONVERSION ELEMENT | Enecoat Technologies Co., Ltd. (JP) | 2026-01-14 | — | — | EP | disclosed |
| CN-121174793-A | Solar cell, preparation method thereof and photovoltaic module | 通威太阳能（成都）有限公司 | 2025-12-19 | — | — | CN | disclosed |
| CN-121078948-A | Perovskite film based on buried interface modification strategy, and preparation method and application thereof | 南京工业大学 | 2025-12-05 | — | — | CN | disclosed |
| CN-121013572-A | Solar cell, preparation method thereof and photovoltaic module | 通威太阳能（成都）有限公司 | 2025-11-25 | — | — | CN | disclosed |
| CN-116283458-B | Simple substance purple smoke agent and preparation method thereof | 南京理工大学 | 2024-09-24 | — | — | CN | disclosed |
| CN-118102740-A | Solar cell and preparation method thereof | 天合光能股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-116283458-A | Simple substance purple smoke agent and preparation method thereof | 南京理工大学 | 2023-06-23 | — | — | CN | disclosed |
| CN-115989072-A | Lichen extract-based formulation for cervidae animals | 兽医医药动力学有限责任公司 | 2023-04-18 | — | — | CN | disclosed |
| EP-2185573-A2 | HIGHLY VISIBLE CHROMOSOME-SPECIFIC PROBES AND RELATED METHODS | Cellay, Inc. (US) | 2010-05-19 | — | — | EP | disclosed |
| US-20090215643-A1 | Highly Visible Chromosome-Specific Probes and Related Methods | CELLAY, LLC (US) | 2009-08-27 | — | — | US | disclosed |
| WO-2009015359-A2 | HIGHLY VISIBLE CHROMOSOME-SPECIFIC PROBES AND RELATED METHODS | CELLAY, LLC (US) | 2009-01-29 | — | — | WO | disclosed |
| EP-1705254-A2 | Compositions and methods using platinum for nucleic acid labeling | Stratagene California (US) | 2006-09-27 | — | — | EP | disclosed |
| EP-1373572-B1 | COMPOSITIONS AND METHODS USING PLATINUM COMPOUNDS FOR NUCLEIC ACID LABELING | STRATAGENE CALIFORNIA (US) | 2006-07-26 | — | — | EP | disclosed |
| US-6825330-B2 | A PLATINUM COMPOUND COVELENTLY ATTACHED TO A DETACTABLE MARKER VIA A LINKER (LINKER IS A GROUP JOINING NITROGEN TO A FLUOROPHORE, A CHROMOPHORE, A RADIOLABEL, AN ENZYME OR AN AFFINITY TAG) | STRATAGENE CALIFORNIA | 2004-11-30 | — | — | US | disclosed |
| EP-1373572-A4 | COMPOSITIONS AND METHODS USING PLATINUM COMPOUNDS FOR NUCLEIC ACID LABELING | STRATAGENE INC (US) | 2004-07-14 | — | — | EP | disclosed |
| EP-1373572-A2 | COMPOSITIONS AND METHODS USING PLATINUM COMPOUNDS FOR NUCLEIC ACID LABELING | Stratagene California (US) | 2004-01-02 | — | — | EP | disclosed |
| US-20020165369-A1 | Compositions and methods using platinum compounds for nucleic acid labeling | STRATAGENE | 2002-11-07 | — | — | US | disclosed |
| WO-2002069898-A2 | COMPOSITIONS AND METHODS USING PLATINUM COMPOUNDS FOR NUCLEIC ACID LABELING | STRATAGENE (US) | 2002-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020165369-A1 | Compositions and methods using platinum compounds for nucleic acid labeling | PCNA, CXCR3, APEX1 | NFKB1 3586/4885TSHR 2322/4885CA12 197/4885 |
| US-20090215643-A1 | Highly Visible Chromosome-Specific Probes and Related Methods | DDX21, INCENP, HNRNPH3 | NFKB1 3687/4885TSHR 4538/4885CA12 2500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.